119 related articles for article (PubMed ID: 8549336)
1. Mechanisms of resistance to fluoroquinolones: state-of-the-art 1992-1994.
Piddock LJ
Drugs; 1995; 49 Suppl 2():29-35. PubMed ID: 8549336
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of fluoroquinolone resistance: an update 1994-1998.
Piddock LJ
Drugs; 1999; 58 Suppl 2():11-8. PubMed ID: 10553699
[TBL] [Abstract][Full Text] [Related]
3. Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
Chen S; Cui S; McDermott PF; Zhao S; White DG; Paulsen I; Meng J
Antimicrob Agents Chemother; 2007 Feb; 51(2):535-42. PubMed ID: 17043131
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the MexC-MexD-OprJ multidrug efflux system in DeltamexA-mexB-oprM mutants of Pseudomonas aeruginosa.
Gotoh N; Tsujimoto H; Tsuda M; Okamoto K; Nomura A; Wada T; Nakahashi M; Nishino T
Antimicrob Agents Chemother; 1998 Aug; 42(8):1938-43. PubMed ID: 9687387
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of resistance to quinolones.
Cambau E; Gutmann L
Drugs; 1993; 45 Suppl 3():15-23. PubMed ID: 7689446
[TBL] [Abstract][Full Text] [Related]
6. Effect of transcriptional activators RamA and SoxS on expression of multidrug efflux pumps AcrAB and AcrEF in fluoroquinolone-resistant Salmonella Typhimurium.
Zheng J; Cui S; Meng J
J Antimicrob Chemother; 2009 Jan; 63(1):95-102. PubMed ID: 18984645
[TBL] [Abstract][Full Text] [Related]
7. [Mechanisms for the development of quinolone resistance].
Kojima M
Nihon Rinsho; 1997 May; 55(5):1252-60. PubMed ID: 9155183
[TBL] [Abstract][Full Text] [Related]
8. Development of multiple-antibiotic-resistant (Mar) mutants of Pseudomonas aeruginosa after serial exposure to fluoroquinolones.
Zhanel GG; Karlowsky JA; Saunders MH; Davidson RJ; Hoban DJ; Hancock RE; McLean I; Nicolle LE
Antimicrob Agents Chemother; 1995 Feb; 39(2):489-95. PubMed ID: 7726519
[TBL] [Abstract][Full Text] [Related]
9. Single or double mutational alterations of gyrA associated with fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli.
Bachoual R; Ouabdesselam S; Mory F; Lascols C; Soussy CJ; Tankovic J
Microb Drug Resist; 2001; 7(3):257-61. PubMed ID: 11759087
[TBL] [Abstract][Full Text] [Related]
10. [A study on the resistance of Staphylococcus aureus and the mechanisms of its resistance to fluoroquinolone].
Lei Y; Gui X; Feng G
Zhonghua Nei Ke Za Zhi; 2001 Mar; 40(3):176-9. PubMed ID: 11798575
[TBL] [Abstract][Full Text] [Related]
11. High-level fluoroquinolone resistance in a Salmonella typhimurium isolate due to alterations in both gyrA and gyrB genes.
Heisig P
J Antimicrob Chemother; 1993 Sep; 32(3):367-77. PubMed ID: 8262859
[TBL] [Abstract][Full Text] [Related]
12. Role of efflux pumps and topoisomerase mutations in fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli.
Ge B; McDermott PF; White DG; Meng J
Antimicrob Agents Chemother; 2005 Aug; 49(8):3347-54. PubMed ID: 16048946
[TBL] [Abstract][Full Text] [Related]
13. Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance.
Akasaka T; Tanaka M; Yamaguchi A; Sato K
Antimicrob Agents Chemother; 2001 Aug; 45(8):2263-8. PubMed ID: 11451683
[TBL] [Abstract][Full Text] [Related]
14. Role of efflux pumps and mutations in genes for topoisomerases II and IV in fluoroquinolone-resistant Pseudomonas aeruginosa strains.
Oh H; Stenhoff J; Jalal S; Wretlind B
Microb Drug Resist; 2003; 9(4):323-8. PubMed ID: 15000738
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of quinolone resistance.
Wiedemann B; Heisig P
Infection; 1994; 22 Suppl 2():S73-9. PubMed ID: 7927834
[TBL] [Abstract][Full Text] [Related]
16. Quinolone mode of action.
Hooper DC
Drugs; 1995; 49 Suppl 2():10-5. PubMed ID: 8549276
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of resistance to commonly used non-betalactam drugs in Streptococcus pneumoniae.
Widdowson CA; Klugman KP
Semin Respir Infect; 1999 Sep; 14(3):255-68. PubMed ID: 10501313
[TBL] [Abstract][Full Text] [Related]
18. [Susceptibility of 570 Pseudomonas aeruginosa strains to 11 antimicrobial agents and the mechanism of its resistance to fluoroquinolones].
Lei YC; Wang HB; Sun ZY; Shen ZY
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):403-7. PubMed ID: 12820918
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of fluoroquinolone resistance.
Chen FJ; Lo HJ
J Microbiol Immunol Infect; 2003 Mar; 36(1):1-9. PubMed ID: 12741725
[TBL] [Abstract][Full Text] [Related]
20. The AcrB multidrug transporter plays a major role in high-level fluoroquinolone resistance in Salmonella enterica serovar typhimurium phage type DT204.
Baucheron S; Imberechts H; Chaslus-Dancla E; Cloeckaert A
Microb Drug Resist; 2002; 8(4):281-9. PubMed ID: 12523625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
